We are registered as an independent intermediary for medicines with the Dutch Ministry of Health
How to buy Cotellic:
You can order Cotellic (cobimetinib) via TheSocialMedwork if the drug has not been approved and/or is not available in the patient's country. TheSocialMedwork - helping patients and doctors access the latest approved medicines and at the lowest price possible worldwide.
Unresectable or metastatic melanoma with a BRAF V600E or V600K mutation
Mode of Action
Kinase inhibitor (chemotherapy)
EMA approved (EU); FDA approved (USA); TGA approved (AUS)
Who is cobimetinib for?
Cotellic (cobimetinib) is indicated in combination with vemurafenib for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation. The presence of BRAF V600E or V600K mutation in tumour samples needs to be confirmed prior to initiation of treatment .
Complete information about cobimetinib dosage and administration can be found here . The standard dosage is:
60 mg orally once daily for the first 21 days of each 28-day cycle until disease progression or unacceptable toxicity
confirm the presence of BRAF V600E or V600K mutation in tumour sample prior to initiation of treatment
Consult your treating doctor for personalised dosing.
What is cobimetinib and how does it work?
Cobimetinib is a cancer medicine used to treat adults with unresectable or metastatic melanoma with a BRAF V600E or V600K Mutation  The active substance in Cotellic, cobimetinib, is a kinase inhibitor. In melanoma with the BRAF V600 mutation, an abnormal form of the protein BRAF is produced, which switches on a protein (MEK), involved in stimulating normal cell division. This encourages the cancer to develop by allowing uncontrolled division of the cancer cells. By blocking this protein cobimetinib slows down the growth and spread of the cancer. Cobimetinib is only given to patients whose melanoma is caused by the BRAF V600 mutation and must be used in combination with the BRAF inhibitor vemurafenib . Vemurafenib is an anticancer medicine that has been widely approved (e.g. by FDA since 2011 , EMA since 2012 , and TGA since 2012 .
The approvals were based on a study (coBRIM) involving 495 patients with BRAF V600 positive unresectable locally advanced or metastatic melanoma. Participants received either vemurafenib plus placebo or vemurafenib plus cobimetinib. The evaluation was primarily based on the progression free survival (PFS). Secondary efficacy endpoints included overall survival (OS), objective response rate (ORR), and duration of response (DoR) . The PFS is the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse . The OS is the time from the start of the study to the death of the patient . The ORR is the portion of patients with a tumour size reduction of a predefined amount for a minimum time period . The DoR is the time from documentation of tumour response to disease progression . Patients taking cobimetinib plus vemurafenib (N = 247) resulted in a median PFS of 5 months longer than those taking vemurafenib plus placebo (N = 248) (12.3 months (95 % CI 9.5, 13.4) vs. to 7.2 months (95% CI 5.6, 7.5) ). The median OS in the cobimetinib cohort was 22.3 months (95 % CI 20.3, Not Evaluable) vs 17.4 (CI 95 % 15.0, 19.8) . The ORR was 69.6 % (95 % CI 63.5 %, 75.3 %) with cobimetinib and 50.0 % (95 % CI 43.6 %, 56.4 %)  without. The median DoR was 13 months (95 % CI 11.1, 16.6)  when cobimetinib was included in the treatment and 9.2 months (95 % CI 7.5, 12.8)  for patients that took vemurafenib plus placebo.
Buyer There is a 6% tax on medicines + 21% tax on shipping for EU individuals
Shipping Cost Estimate
*Once you provide us with the exact shipping address, the actual price may vary.
Send this price estimate to your email address
Ordering with TheSocialMedwork is a safe and legal way to import a prescription medicine that has been approved in another country, but is not yet available where you live.
If you think that this medicine may be suitable for treating your condition, get in touch.
We'll answer any questions you might have and provide you with further information. Select the
tab to get a close estimate of the full cost of the medicine including delivery.
If you would like us to provide you with a precise quote we'll need to know the exact address of where you want us to send your medicine to.
2. Chat with your doctor
About whether this treatment might be suitable for you. In order to place an order with us, you’ll need to provide us with a prescription from your doctor who must be based in the same country where the medicine will be shipped to.
3. Place your order
Once you have your doctor's prescription you’re ready to place an order with us. Payment can be made by credit card, electronic bank transfer or Paypal.
As soon as we receive your payment we’ll process your order and your medicine will be shipped to you via a pharmacy.
Delivery time can vary from country to country but usually takes 1 to 3 weeks.
We'll send you a tracking number and keep you up to date on the status of your order.
Rest assured that we'll guide you through the entire process.
We'll let you know exactly what regulations need to be followed and the specific documentation you'll need to import the medicine into your country so that you get your treatment as quickly as possible. Ask us a question
"TheSocialMedwork helped us to get the medicine, which was not accessible for us, in the shortest possible time."
- Haoyu, China.
Registered with the Dutch Ministry of Health as an independent intermediary, Registration number 6730 BEM
DISCLAIMER: The Services of TheSocialMedwork do not replace a physician-patient relationship and are not intended as medical advice. TheSocialMedwork provides patients and physicians with existing treatment options abroad and creates access to these options after the patient and physician have made a professional decision.
Terms and Conditions